WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: MAY ISSUE PUBLISHED

    MAY 2023 Issue has been successfully launched on 1 MAY 2023.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR May 2023 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

A STUDY OF THE PREVALENCE OF LIVER FUNCTION DISORDERS IN PATIENTS WITH TYPE II DIABETES MELLITUS

Zeinab Saker* and Ruba Salman

ABSTRACT

Background: Type 2 diabetes mellitus(T2DM) represents a disorder of glucose metabolism that is characterized by hyperglycemia and insulin resistance. Liver involvement in T2DM is recognized in the form of non-alcoholic fatty liver disease (NAFLD) which can range from simple steatosis to liver cirrhosis. Objective: The aim of this study was to determine the prevalence of liver transaminase disorders in T2DM patients, and the association with glycemic control. Patients and Methods: A Descriptive Observational Cross Sectional study was conducted for the period one year (2021 –2022) at Tishreen University Hospital in Lattakia-Syria. The study included all T2DM patients older than 18 years with a duration of diagnosis disease longer than 6 months. Alanine transaminase(ALT) and Aspartate transaminase(AST) were measured for all patients with abdominal ultrasound. Results: The study included 189 patients with T2DM. Fatty liver disease was detected in 72 cases (38.1%) which was associated with elevated levels of ALT in 60 cases (83.3%) and AST in 24 cases (33.3%). Elevated levels of ALT were associated significantly with increasing body mass index BMI, fasting plasma glucose FPG, glycosylated hemoglobin HbA1c, total cholesterol TC, triglyceride TG, low-density lipoprotein LDL, and decreasing high density lipoprotein HDL (p<0.05). Elevated levels of ALT were observed more frequently in patients with fatty liver disease (76.9% versus 23.1%, p:0.0001). Elevated levels of AST were associated significantly with increasing BMI, FPG, HbA1c, TC, TG, and decreasing HDL (p<0.05). Elevated levels of AST were observed more frequently in patients with fatty liver disease (72.7% versus 27.3%, p:0.0001). Conclusion: The current study demonstrated presence of fatty liver disease in important percentage of T2DM patients, and elevated levels of ALT were observed more frequently, so that early diagnosis of diabetes and initiating of therapeutic intervention is considered essential to improve final outcome.

[Full Text Article]